Mabtech and Sai Life Sciences partner to enhance immunology research using EYRA at Sai Boston
Mabtech and Sai will jointly provide advanced immunology assay services powered by the EYRA platform, which is installed at Sai’s Boston discovery site.
Mabtech and Sai will jointly provide advanced immunology assay services powered by the EYRA platform, which is installed at Sai’s Boston discovery site.
The new facility will double the company’s Process R&D capacity, while adding new capabilities.
The alliance simplifies the process from preclinical research to initial human trials with coordinated project management and a single contact point.
Sai Life Sciences’ investment aligns with its strategy to focus on niche, high-value pharmaceutical segments.
The Peptide Research Center is equipped with automation, robotics, and more. It is designed to support pharmaceutical and biotech innovators with specialized services.